» Articles » PMID: 12058091

Effects of Subcortical Ischemic Vascular Dementia and AD on Entorhinal Cortex and Hippocampus

Overview
Journal Neurology
Specialty Neurology
Date 2002 Jun 12
PMID 12058091
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the effects of subcortical ischemic vascular dementia (SIVD) and AD on entorhinal cortex (ERC) and hippocampus.

Methods: Thirty-eight cognitively normal subjects, 18 patients with SIVD, and 22 patients with AD were included. Volumes of ERC and hippocampus were manually measured based on MRI. Global cerebral changes of cortical gray matter, subcortical gray matter, white matter, sulcal CSF, ventricular CSF (vCSF), and white matter signal hyperintensities (WMSH) were assessed.

Results: Patients with SIVD had 21.7% (p < 0.01) smaller ERC and 18.2% (p < 0.01) smaller hippocampi than cognitively normal subjects and 24.4% (p < 0.01) larger ERC and 11.1% (p < 0.05) larger hippocampi than patients with AD. In addition, patients with SIVD had less cortical gray matter and white matter and more vCSF and WMSH (all p < 0.01) than cognitively normal subjects and more vCSF and WMSH (p < 0.01) than patients with AD. The volumes of ERC and hippocampus were positively correlated to similar extents (p < 0.01) in SIVD and AD. Cortical gray matter loss was positively correlated (p < 0.01) with hippocampal atrophy, but not with ERC atrophy, in SIVD and AD. Hippocampal volume alone could classify 82% of patients with SIVD from cognitively normal subjects and 63% of patients with SIVD from subjects with AD. Adding global cerebral changes to hippocampus substantially improved the classification to 96% between patients with SIVD and cognitively normal subjects and 83% between subjects with SIVD and those with AD, whereas adding ERC change to hippocampus did not significantly improve the discrimination.

Conclusions: The entorhinal cortex and hippocampus are less affected by subcortical ischemic vascular dementia than by AD.

Citing Articles

Gray and White Matter Voxel-Based Morphometry of Alzheimer's Disease With and Without Significant Cerebrovascular Pathologies.

Saha C, Figley C, Dastgheib Z, Lithgow B, Moussavi Z Neurosci Insights. 2024; 19:26331055231225657.

PMID: 38304550 PMC: 10832430. DOI: 10.1177/26331055231225657.


Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.

Molinder A, Ziegelitz D, Maier S, Eckerstrom C BMC Neurol. 2021; 21(1):289.

PMID: 34301202 PMC: 8305846. DOI: 10.1186/s12883-021-02325-2.


Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.

Moore E, Gifford K, Khan O, Liu D, Pechman K, Acosta L Alzheimers Dement. 2020; 16(6):883-895.

PMID: 32378327 PMC: 7781154. DOI: 10.1002/alz.12087.


Neuroimaging in aging and neurologic diseases.

Risacher S, Saykin A Handb Clin Neurol. 2019; 167:191-227.

PMID: 31753134 PMC: 9006168. DOI: 10.1016/B978-0-12-804766-8.00012-1.


Reduced Regional Cerebral Blood Flow Relates to Poorer Cognition in Older Adults With Type 2 Diabetes.

Bangen K, Werhane M, Weigand A, Edmonds E, Delano-Wood L, Thomas K Front Aging Neurosci. 2018; 10:270.

PMID: 30250430 PMC: 6139361. DOI: 10.3389/fnagi.2018.00270.


References
1.
Fein G, DI Sclafani V, Tanabe J, Cardenas V, Weiner M, Jagust W . Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000; 55(11):1626-35. PMC: 2733356. DOI: 10.1212/wnl.55.11.1626. View

2.
Du A, Schuff N, AMEND D, Laakso M, Hsu Y, Jagust W . Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001; 71(4):441-7. PMC: 1763497. DOI: 10.1136/jnnp.71.4.441. View

3.
Tierney M, Black S, Szalai J, SNOW W, Fisher R, Nadon G . Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol. 2001; 58(10):1654-9. DOI: 10.1001/archneur.58.10.1654. View

4.
Hachinski V, Iliff L, Zilhka E, DU BOULAY G, McAllister V, Marshall J . Cerebral blood flow in dementia. Arch Neurol. 1975; 32(9):632-7. DOI: 10.1001/archneur.1975.00490510088009. View

5.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View